Red blood cell utilization and subsequent incidence of alloimmunization to the transfused RBCs in patients receiving daratumumab
Latest Information Update: 29 Apr 2022
At a glance
- Drugs Daratumumab (Primary)
- Indications Haematological malignancies
- Focus Adverse reactions
Most Recent Events
- 29 Apr 2022 New trial record